Suggestions
Tom Ruggia
Chief Executive Officer at Samsara Vision
Tom Ruggia is the Chief Executive Officer of Samsara Vision, a company he joined in July 2020. With nearly 25 years of experience in the ophthalmology sector, Ruggia has a robust background in developing and commercializing medical devices aimed at improving vision, particularly for individuals with untreatable retinal disorders.
Professional Background
Before his role at Samsara Vision, Ruggia held significant positions at major companies in the healthcare industry:
- Johnson & Johnson: He served as Vice President of Worldwide Customer Experience and Ocular Surface Disease, where he managed global commercial teams focused on customer strategy and service for five years.
- Alcon (a division of Novartis): Ruggia spent 15 years in various sales and marketing roles, contributing to the company's growth in the ophthalmic market.
Ruggia’s educational background includes a Bachelor of Science degree from The College of New Jersey, which he obtained in 1998.125
Samsara Vision's Mission and Achievements
Under Ruggia's leadership, Samsara Vision focuses on innovative medical technologies, particularly the Smaller-Incision, New Generation Implantable Miniature Telescope (SING IMT). This device aims to significantly enhance the quality of life for patients suffering from late-stage age-related macular degeneration (AMD). Since its introduction, over 350 patients have received this implant across Europe.12
Ruggia emphasizes the company's commitment to addressing "non-preventable" blindness and aims to establish the SING IMT as a standard treatment option globally. Future goals include expanding availability in CE-referenced countries and securing FDA approval for the device in the United States.12
Personal Insights
Ruggia is passionate about improving patient lives and believes strongly in the mission of Samsara Vision. His leadership style focuses on building trust with stakeholders and ensuring that the company adheres to high ethical standards while pursuing its goals.34
